Abstract Background Acute Respiratory Distress Syndrome (ARDS) is a severe condition
with high mortality and morbidity rates. Evidence on the effectiveness of pharmacological …

Background Standard therapy for COVID-19 is continuously evolving. Autopsy studies
showed high prevalence of platelet-fibrin-rich microthrombi in several organs. The aim of the …

Objectives: Streptococcus pneumoniae is the most common causative pathogen in
community-acquired pneumonia. In patients, thrombocytopenia is correlated with an …

The study investigates the prognostic value of the platelet count in patients with cardiogenic
shock (CS). Limited data regarding the prognostic value of platelets in patients suffering from …

Background Platelet activation and consumption are common in critically ill patients and are
associated with poorer prognosis. Mean platelet volume is a simple surrogate for platelet …

Because the formation of platelet thrombi has been incriminated in the development of the
adult respiratory distress syndrome (ARDS), we tested trie hypothesis that early …

Introduction Acute respiratory distress syndrome (ARDS) is a common clinical syndrome
with high mortality and long-term morbidity. To date there is no effective pharmacological …

Antiplatelet therapy for the treatment of cardiovascular diseases is common in the ageing
population. Whether this therapy exacerbates brain injury after head trauma is an important …

Interventions Patients were randomized to receive either open-label aspirin (n= 565), a
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …

We read with great interest the article of the PLOT-ICU study performed by Anthon et al.
deciphering thrombocytopenia and platelet transfusion landscapes in patients admitted in …